首页> 美国卫生研究院文献>Genes >Steric Clash in the SET Domain of Histone Methyltransferase NSD1 as a Cause of Sotos Syndrome and Its Genetic Heterogeneity in a Brazilian Cohort
【2h】

Steric Clash in the SET Domain of Histone Methyltransferase NSD1 as a Cause of Sotos Syndrome and Its Genetic Heterogeneity in a Brazilian Cohort

机译:组蛋白甲基转移酶NSD1的SET域中的立体冲突是Sotos综合征的原因及其在巴西队列中的遗传异质性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Most histone methyltransferases (HMTase) harbor a predicted Su(var)3–9, Enhancer-of-zeste, Trithorax (SET) domain, which transfers a methyl group to a lysine residue in their substrates. Mutations of the SET domains were reported to cause intellectual disability syndromes such as Sotos, Weaver, or Kabuki syndromes. Sotos syndrome is an overgrowth syndrome with intellectual disability caused by haploinsufficiency of the nuclear receptor binding SET domain protein 1 (NSD1) gene, an HMTase at 5q35.2–35.3. Here, we analyzed NSD1 in 34 Brazilian Sotos patients and identified three novel and eight known mutations. Using protein modeling and bioinformatic approaches, we evaluated the effects of one novel (I2007F) and 21 previously reported missense mutations in the SET domain. For the I2007F mutation, we observed conformational change and loss of structural stability in Molecular Dynamics (MD) simulations which may lead to loss-of-function of the SET domain. For six mutations near the ligand-binding site we observed in simulations steric clashes with neighboring side chains near the substrate S-Adenosyl methionine (SAM) binding site, which may disrupt the enzymatic activity of NSD1. These results point to a structural mechanism underlying the pathology of the NSD1 missense mutations in the SET domain in Sotos syndrome. NSD1 mutations were identified in only 32% of the Brazilian Sotos patients in our study cohort suggesting other genes (including unknown disease genes) underlie the molecular etiology for the majority of these patients. Our studies also found NSD1 expression to be profound in human fetal brain and cerebellum, accounting for prenatal onset and hypoplasia of cerebellar vermis seen in Sotos syndrome.
机译:大多数组蛋白甲基转移酶(HMTase)都带有一个预测的Su(var)3-9,增强型Zeste的Trithorax(SET)域,该结构域将一个甲基转移到其底物中的赖氨酸残基上。据报道,SET结构域的突变会导致智障综合征,例如Sotos,Weaver或Kabuki综合征。 Sotos综合征是一种具有智力残疾的过度生长综合征,是由核受体结合SET结构域蛋白1(NSD1)基因(5q35.2-35.3处的HMTase)单倍缺乏引起的。在这里,我们分析了34位巴西Sotos患者的NSD1,并确定了3个新突变和8个已知突变。使用蛋白质建模和生物信息学方法,我们评估了SET域中一种新型(I2007F)和21种先前报道的错义突变的作用。对于I2007F突变,我们在分子动力学(MD)模拟中观察到构象变化和结构稳定性丧失,这可能导致SET结构域功能丧失。对于配体结合位点附近的六个突变,我们在模拟中观察到与底物S-腺苷甲硫氨酸(SAM)结合位点附近的相邻侧链发生空间冲突,这可能会破坏NSD1的酶活性。这些结果指出了Sotos综合征SET域中NSD1错义突变的病理学基础的结构机制。在我们的研究队列中仅32%的巴西Sotos患者中发现了NSD1突变,这表明其他基因(包括未知疾病基因)是大多数此类患者的分子病因基础。我们的研究还发现,NSD1在人类胎儿脑和小脑中的表达很深,这说明了在Sotos综合征中发现的小脑ver的产前发作和发育不全。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号